Physician profile
Tyler David Owitz
NPI 1467176248
$308.36
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $37.14 · 2023: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $73.80 | 2022-2023 | Jardiance, Emgality |
| Boston Scientific Corporation | $45.46 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $45.25 | 2022-2023 | Saphnelo, Farxiga |
| Gilead Sciences, INC. | $24.22 | 2023 | |
| Harmony Biosciences LLC | $24.18 | 2023 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.67 | 2023 | Synjardy, Jardiance, Tradjenta |
| Takeda Pharmaceuticals U.S.A., INC. | $18.82 | 2023 | Cuvitru |
| Otsuka America Pharmaceutical, INC. | $14.63 | 2023 | Abilify Mycite |
| Amgen INC. | $14.29 | 2023 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $14.29 | 2023 | Pifeltro, Delstrigo, Dificid |
| Endo Pharmaceuticals INC. | $13.75 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Owitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.